These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
250 related articles for article (PubMed ID: 27753464)
21. Structure- and Ligand-Dynamics-Based Design of Novel Antibiotics Targeting Lipid A Enzymes LpxC and LpxH in Gram-Negative Bacteria. Zhou P; Hong J Acc Chem Res; 2021 Apr; 54(7):1623-1634. PubMed ID: 33720682 [TBL] [Abstract][Full Text] [Related]
22. The first low microM SecA inhibitors. Chen W; Huang YJ; Gundala SR; Yang H; Li M; Tai PC; Wang B Bioorg Med Chem; 2010 Feb; 18(4):1617-25. PubMed ID: 20096592 [TBL] [Abstract][Full Text] [Related]
23. Biphasic actions of SecA inhibitors on Prl/Sec suppressors: Possible physiological roles of SecA-only channels. Hsieh YH; Zhang H; Jin J; Dai C; Jiang C; Wang B; Tai PC Biochem Biophys Res Commun; 2017 Jan; 482(2):296-300. PubMed ID: 27856243 [TBL] [Abstract][Full Text] [Related]
24. Development of a Microemulsion Formulation for Antimicrobial SecA Inhibitors. Hu J; Akula N; Wang N PLoS One; 2016; 11(3):e0150433. PubMed ID: 26963811 [TBL] [Abstract][Full Text] [Related]
26. Multidrug Efflux Pumps and the Two-Faced Janus of Substrates and Inhibitors. Zgurskaya HI; Walker JK; Parks JM; Rybenkov VV Acc Chem Res; 2021 Feb; 54(4):930-939. PubMed ID: 33539084 [TBL] [Abstract][Full Text] [Related]
27. Dynamic distribution of the SecA and SecY translocase subunits and septal localization of the HtrA surface chaperone/protease during Streptococcus pneumoniae D39 cell division. Tsui HC; Keen SK; Sham LT; Wayne KJ; Winkler ME mBio; 2011; 2(5):. PubMed ID: 21990615 [TBL] [Abstract][Full Text] [Related]
28. The way is the goal: how SecA transports proteins across the cytoplasmic membrane in bacteria. Cranford-Smith T; Huber D FEMS Microbiol Lett; 2018 Jun; 365(11):. PubMed ID: 29790985 [TBL] [Abstract][Full Text] [Related]
29. Mechanisms of Rose Bengal inhibition on SecA ATPase and ion channel activities. Hsieh YH; Huang YJ; Jin JS; Yu L; Yang H; Jiang C; Wang B; Tai PC Biochem Biophys Res Commun; 2014 Nov; 454(2):308-12. PubMed ID: 25450394 [TBL] [Abstract][Full Text] [Related]
30. Activity of the type I signal peptidase inhibitor MD3 against multidrug-resistant Gram-negative bacteria alone and in combination with colistin. Personne Y; Curtis MA; Wareham DW; Waite RD J Antimicrob Chemother; 2014 Dec; 69(12):3236-43. PubMed ID: 25134721 [TBL] [Abstract][Full Text] [Related]
31. Potent Antibiotics Active against Multidrug-Resistant Gram-Negative Bacteria. Otsuka Y Chem Pharm Bull (Tokyo); 2020; 68(3):182-190. PubMed ID: 32115524 [TBL] [Abstract][Full Text] [Related]
32. Identification of small molecule inhibitors against SecA of Candidatus Liberibacter asiaticus by structure based design. Akula N; Trivedi P; Han FQ; Wang N Eur J Med Chem; 2012 Aug; 54():919-24. PubMed ID: 22703844 [TBL] [Abstract][Full Text] [Related]
33. Identification of a gene fragment which codes for the 364 amino-terminal amino acid residues of a SecA homologue from Bacillus subtilis: further evidence for the conservation of the protein export apparatus in gram-positive and gram-negative bacteria. Overhoff B; Klein M; Spies M; Freudl R Mol Gen Genet; 1991 Sep; 228(3):417-23. PubMed ID: 1832735 [TBL] [Abstract][Full Text] [Related]
34. SecA Cotranslationally Interacts with Nascent Substrate Proteins In Vivo. Huber D; Jamshad M; Hanmer R; Schibich D; Döring K; Marcomini I; Kramer G; Bukau B J Bacteriol; 2017 Jan; 199(2):. PubMed ID: 27795329 [TBL] [Abstract][Full Text] [Related]
35. Extending the Potency and Lifespan of Antibiotics: Inhibitors of Gram-Negative Bacterial Efflux Pumps. Duffey M; Jumde RP; da Costa RMA; Ropponen HK; Blasco B; Piddock LJV ACS Infect Dis; 2024 May; 10(5):1458-1482. PubMed ID: 38661541 [TBL] [Abstract][Full Text] [Related]
36. Dimeric SecA couples the preprotein translocation in an asymmetric manner. Tang Y; Pan X; Chen Y; Tai PC; Sui SF PLoS One; 2011 Jan; 6(1):e16498. PubMed ID: 21304597 [TBL] [Abstract][Full Text] [Related]
37. Simplified Novel Muraymycin Analogues; using a Serine Template Strategy for Linking Key Pharmacophores. Patel B; Kerr RV; Malde AK; Zunk M; Bugg TDH; Grant G; Rudrawar S ChemMedChem; 2020 Aug; 15(15):1429-1438. PubMed ID: 32476294 [TBL] [Abstract][Full Text] [Related]
38. Structure-based discovery of LpxC inhibitors. Zhang J; Chan A; Lippa B; Cross JB; Liu C; Yin N; Romero JA; Lawrence J; Heney R; Herradura P; Goss J; Clark C; Abel C; Zhang Y; Poutsiaka KM; Epie F; Conrad M; Mahamoon A; Nguyen K; Chavan A; Clark E; Li TC; Cheng RK; Wood M; Andersen OA; Brooks M; Kwong J; Barker J; Parr IB; Gu Y; Ryan MD; Coleman S; Metcalf CA Bioorg Med Chem Lett; 2017 Apr; 27(8):1670-1680. PubMed ID: 28302397 [TBL] [Abstract][Full Text] [Related]